BackIntercept Pharmaceuticals Overview

Intercept Pharmaceuticals Receivables

Intercept Pharmaceuticals's receivables is $32M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$32.48M
↑ 24.12% YoYΔ $6.31M vs prior year quarter

Peer trimmed avg / median

Loading

Intercept Pharmaceuticals Receivables History

Loading

Intercept Pharmaceuticals vs. peers: Receivables Comparison

Loading

Intercept Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Intercept Pharmaceuticals (ICPT) FAQ

As of the most recent data (September 2023), ICPT shows a receivables of $32M. That compares with $26M in the prior-year period — up 24.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ICPT's receivables is now $32M (was $26M) — a 24.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Intercept Pharmaceuticals is outperforming or lagging.

Tracking ICPT's receivables over time shows whether Intercept Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $32M That compares with $26M in the prior-year period — up 24.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Intercept Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $32M) with ownership activity and broader fundamentals.

Intercept Pharmaceuticals's receivables is $32M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.